NASDAQ:AEMD - Aethlon Medical Stock Price, News, & Analysis

$0.36
+0.01 (+2.86 %)
(As of 06/19/2019 04:00 PM ET)
Today's Range
$0.34
Now: $0.36
$0.37
50-Day Range
$0.32
MA: $0.46
$0.76
52-Week Range
$0.30
Now: $0.36
$1.74
Volume1,500 shs
Average Volume152,708 shs
Market Capitalization$6.83 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32
Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AEMD
CUSIPN/A
Phone858-459-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150,000.00
Book Value$0.36 per share

Profitability

Net Income$-5,670,000.00

Miscellaneous

Employees6
Market Cap$6.83 million
Next Earnings Date6/21/2019 (Estimated)
OptionableNot Optionable

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.

Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) announced its quarterly earnings results on Monday, February, 11th. The medical equipment provider reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.04. View Aethlon Medical's Earnings History.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release their next quarterly earnings announcement on Friday, June 21st 2019. View Earnings Estimates for Aethlon Medical.

What price target have analysts set for AEMD?

1 brokerages have issued twelve-month price targets for Aethlon Medical's shares. Their predictions range from $3.00 to $3.00. On average, they anticipate Aethlon Medical's stock price to reach $3.00 in the next year. This suggests a possible upside of 733.3% from the stock's current price. View Analyst Price Targets for Aethlon Medical.

What is the consensus analysts' recommendation for Aethlon Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aethlon Medical.

Has Aethlon Medical been receiving favorable news coverage?

News articles about AEMD stock have trended somewhat negative this week, InfoTrie reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aethlon Medical earned a coverage optimism score of -1.2 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Aethlon Medical.

Who are some of Aethlon Medical's key competitors?

Some companies that are related to Aethlon Medical include Arrayit (ARYC), Precipio (PRPO), Scientific Industries (SCND), Pressure Biosciences (PBIO) and PositiveID (PSID).

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Cytosorbents (CTSO), AT&T (T), Novavax (NVAX), NewLink Genetics (NLNK), Agile Therapeutics (AGRX), Ampliphi Biosciences (APHB), Ur-Energy (URG), Allena Pharmaceuticals (ALNA), Celldex Therapeutics (CLDX) and Auris Medical (EARS).

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the folowing people:
  • Mr. James B. Frakes, CFO, Sr. VP of Fin. & Sec. (Age 62)
  • Mr. James A. Joyce, Consultant (Age 57)
  • Dr. Timothy C. Rodell, Interim CEO & Director (Age 68)
  • Mr. Sunil Sawhney, Head of Clinical Studies
  • Dr. Richard H. Tullis, Consultant (Age 74)

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $0.36.

How big of a company is Aethlon Medical?

Aethlon Medical has a market capitalization of $6.83 million and generates $150,000.00 in revenue each year. The medical equipment provider earns $-5,670,000.00 in net income (profit) each year or ($0.46) on an earnings per share basis. Aethlon Medical employs 6 workers across the globe.View Additional Information About Aethlon Medical.

What is Aethlon Medical's official website?

The official website for Aethlon Medical is http://www.aethlonmedical.com/.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]


MarketBeat Community Rating for Aethlon Medical (NASDAQ AEMD)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  126 (Vote Underperform)
Total Votes:  282
MarketBeat's community ratings are surveys of what our community members think about Aethlon Medical and other stocks. Vote "Outperform" if you believe AEMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Featured Article: What is a support level?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel